EA201491481A1 - Аллергены тимофеевки луговой и способы и применения для модулирования иммунного ответа - Google Patents

Аллергены тимофеевки луговой и способы и применения для модулирования иммунного ответа

Info

Publication number
EA201491481A1
EA201491481A1 EA201491481A EA201491481A EA201491481A1 EA 201491481 A1 EA201491481 A1 EA 201491481A1 EA 201491481 A EA201491481 A EA 201491481A EA 201491481 A EA201491481 A EA 201491481A EA 201491481 A1 EA201491481 A1 EA 201491481A1
Authority
EA
Eurasian Patent Office
Prior art keywords
meadow
methods
allergen
immune response
timofeed
Prior art date
Application number
EA201491481A
Other languages
English (en)
Russian (ru)
Inventor
Алессандро Сетте
Вероник Шюльтен
Говард Грей
Бьерн Питерс
Джейсон Гринбаум
Original Assignee
Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи filed Critical Ла Хойя Инститьют Фор Эллерджи Энд Иммьюнолоджи
Publication of EA201491481A1 publication Critical patent/EA201491481A1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A61K39/36—Allergens from pollen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Botany (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
EA201491481A 2012-02-07 2013-02-07 Аллергены тимофеевки луговой и способы и применения для модулирования иммунного ответа EA201491481A1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261596156P 2012-02-07 2012-02-07
US201261734886P 2012-12-07 2012-12-07
PCT/US2013/025213 WO2013119863A1 (en) 2012-02-07 2013-02-07 Timothy grass allergens and methods and uses for immune response modulation

Publications (1)

Publication Number Publication Date
EA201491481A1 true EA201491481A1 (ru) 2014-11-28

Family

ID=48948025

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201491481A EA201491481A1 (ru) 2012-02-07 2013-02-07 Аллергены тимофеевки луговой и способы и применения для модулирования иммунного ответа

Country Status (13)

Country Link
US (1) US10428124B2 (https=)
EP (1) EP2812026A4 (https=)
JP (1) JP2015513527A (https=)
KR (1) KR20140129124A (https=)
CN (1) CN104203277A (https=)
AU (1) AU2013216993C1 (https=)
BR (1) BR112014019504A2 (https=)
CA (1) CA2864084A1 (https=)
EA (1) EA201491481A1 (https=)
HK (1) HK1204929A1 (https=)
IN (1) IN2014MN01513A (https=)
MX (1) MX2014009285A (https=)
WO (1) WO2013119863A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015054217A2 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for reducing an allergic response in a subject
WO2015054231A1 (en) 2013-10-07 2015-04-16 La Jolla Institute For Allergy And Immunology Methods and uses for identifying responders to allergy therapy
WO2015077442A2 (en) 2013-11-20 2015-05-28 La Jolla Institute For Allergy And Immunology Grass pollen immunogens and methods and uses for immune response modulation
AU2014352986A1 (en) 2013-11-20 2016-06-16 Alk-Abello A/S Pan pollen immunogens and methods and uses thereof for immune response modulation
BR112016011930A2 (pt) 2013-12-23 2017-09-26 Alk Abello As combinações de peptídeos e seus usos em tratamento de alergia de ácaro de poeira
WO2015131053A1 (en) 2014-02-28 2015-09-03 Alk-Abelló A/S Polypeptides derived from phl p and methods and uses thereof for immune response modulation
EP3925968A3 (en) 2014-10-07 2022-03-02 Cytlimic Inc. Hsp70-derived peptide, pharmaceutical composition for treating or preventing cancer using same, immunity inducer, and method for producing antigen-presenting cell
CN113388021A (zh) 2015-03-09 2021-09-14 Cytlimic公司 源于gpc3的肽、使用其的医药组合物、免疫诱导剂、及抗原呈递细胞的制造方法
RU2709015C2 (ru) 2015-04-07 2019-12-13 Ситлимик Инк. Лекарственное средство
CA3023092A1 (en) * 2016-05-03 2017-11-09 Sqz Biotechnologies Company Intracellular delivery of biomolecules to induce tolerance
US11291718B2 (en) 2016-10-11 2022-04-05 Cytlimic Inc. Method for treating cancer by administering a toll-like receptor agonist and LAG-3 IgG fusion protein
CN119086940A (zh) * 2017-04-28 2024-12-06 朋友股份有限公司 变态反应的抗原及其表位
JP7770314B2 (ja) * 2019-11-25 2025-11-14 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 診断及び処置のための抗原ニューロン特異的エノラーゼペプチド
CN120349374B (zh) * 2025-03-25 2025-10-10 长沙理工大学 一种米渣短肽及其在降尿酸中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7214786B2 (en) * 2000-12-14 2007-05-08 Kovalic David K Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement
AUPR775401A0 (en) * 2001-09-18 2001-10-11 Monash University Novel Epitopes and Uses Thereof
EP2392591B1 (de) * 2002-06-25 2018-02-21 Merck Patent GmbH DNA-Sequenz und rekombinante Herstellung des Graspollen-Allergens Phl p 4
RU2323942C2 (ru) 2002-08-19 2008-05-10 Мерк Патент Гмбх ВАРИАНТЫ ОСНОВНОГО АЛЛЕРГЕНА Phl p 1 ИЗ ТИМОФЕЕВКИ ЛУГОВОЙ
WO2004047793A1 (en) * 2002-11-26 2004-06-10 Alk-Abelló A/S Pharmaceutical allergen product
AU2006204997B2 (en) 2005-01-12 2011-09-01 Monsanto Technology, Llc Genes and uses for plant improvement
US20090070897A1 (en) * 2006-01-12 2009-03-12 Goldman Barry S Genes and uses for plant improvement
PL2244734T3 (pl) * 2008-02-01 2017-01-31 Murdoch Childrens Research Institute Sposób indukcji tolerancji na alergen
EP2388268A1 (en) * 2010-05-18 2011-11-23 Stallergenes S.A. Recombinant Der p 2 expressed in Pichia pastoris as a "natural-like" allergen for immunotherapy and diagnostic purposes
US20120100163A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a type 1 hypersensitivity immune response with an unrelated antigen
US20120100164A1 (en) 2010-10-15 2012-04-26 Alk-Abello A/S Suppression of a hypersensitivity immune response with unrelated antigen derived from allergen source material
US9700071B2 (en) * 2012-03-26 2017-07-11 Axcella Health Inc. Nutritive fragments, proteins and methods
JP2015514126A (ja) 2012-04-16 2015-05-18 アルク−アベッロ エイ／エスＡｌｋ−Ａｂｅｌｌｏ Ａ／Ｓ 非特異的アレルギー免疫療法において使用するための植物プロフィリンポリペプチド

Also Published As

Publication number Publication date
BR112014019504A2 (pt) 2017-06-27
CN104203277A (zh) 2014-12-10
IN2014MN01513A (https=) 2015-09-11
US10428124B2 (en) 2019-10-01
JP2015513527A (ja) 2015-05-14
US20150023992A1 (en) 2015-01-22
HK1204929A1 (en) 2015-12-11
EP2812026A4 (en) 2016-04-27
CA2864084A1 (en) 2013-08-15
EP2812026A1 (en) 2014-12-17
MX2014009285A (es) 2015-02-04
AU2013216993B2 (en) 2016-09-15
KR20140129124A (ko) 2014-11-06
AU2013216993C1 (en) 2017-01-19
WO2013119863A1 (en) 2013-08-15
AU2013216993A1 (en) 2014-08-21

Similar Documents

Publication Publication Date Title
EA201491481A1 (ru) Аллергены тимофеевки луговой и способы и применения для модулирования иммунного ответа
CY1120398T1 (el) Ανθρωποποιημενα αντισωματα που αναγνωριζουν αλφα-συνουκλεϊνη
CY1122956T1 (el) Αντισωματα εναντι αντιγονου 2 των δενδριτικων κυτταρων του αιματος και χρησεις αυτων
EA201790109A1 (ru) Толерогенные синтетические наноносители, уменьшающие иммунный ответ на терапевтические белки
EA201690314A1 (ru) Анти-garp-белок и его применения
EA201592107A1 (ru) Доставка иммунодепрессантов, имеющих определенный фармакодинамически эффективный период, и антигена для индукции иммунной толерантности
BR112013020500A2 (pt) anticorpo isolado, recombinante ou purificado
EA201300239A1 (ru) Антитела к fap и способы их применения
BR112016023948A2 (pt) proteínas fc multiméricas
UA104663C2 (xx) Антитіло, що зв'язує cd127$антитело, связывающее cd127
EA201891165A1 (ru) Молекулы, связывающие pd1 и/или lag3
EA201790377A1 (ru) Антитела к глюкагону и их применения
MX357965B (es) Composicion farmaceutica para el tratamiento y/o prevencion de cancer de vesicula biliar.
JO3555B1 (ar) جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري
EA201491357A1 (ru) Анти-lrp5 антитела и способы их применения
EA201391175A1 (ru) Гетеродимерные иммуноглобулины
MX366858B (es) Composicion farmaceutica que comprende un complejo de carga con portador polimerico y al menos y un antigeno proteinico o peptidico.
BR112016011025A2 (pt) polipeptídeos anticorpo e seus usos
NZ723858A (en) Anti-human ox40l antibodies, uses & methods
EA201690898A1 (ru) Способы лечения таупатии
TR201905619T4 (tr) Alerji aşısı olarak peptit taşıyıcı füzyon proteinleri.
EA201491856A1 (ru) Терапевтическое применение белков фактора роста фибробластов 21
EA201591133A1 (ru) СОСТАВЫ В ВИДЕ РАСТВОРА СКОНСТРУИРОВАННЫХ АНТИТЕЛ К IL-23p19
CY1119957T1 (el) Θεραπεια νοσηματων με τη χρηση ανοχογονου φαρμακευτικου παρασκευασματος
MX389320B (es) Anticuerpos anti-tnfrsf25